In HCC, specifically, EMT has been proven to be crucial in determining tumor progression and metastasis, and can be accelerated by various biological factors, such as inflammatory cytokine interleukin 6 (IL-6), JAK2/STAT3 signaling, and dysregulation of Wnt/β-catenin pathway6,7. Here, JAK2 is linked to hepatocellular carcinoma.